Histone deacetylases as targets for treatment of multiple diseases

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Histone deacetylases (HDACs) are enzymes regulating gene transcription by deacetylating histone and non-histone proteins.
• HDACs play roles in cell proliferation, differentiation, and disease pathogenesis.
• HDACs are increasingly recognized as critical therapeutic targets for various diseases.

Purpose of the Study:

• To review the therapeutic applications of HDAC inhibitors across diverse diseases.
• To focus on the anti-cancer, anti-fibrosis, anti-inflammatory, immunomodulatory, and metabolic regulatory effects of HDAC inhibitors.

Main Methods:

• Literature review of studies on HDAC inhibitors.
• Analysis of preclinical and clinical data regarding HDAC inhibitor efficacy.
• Synthesis of information on HDAC inhibitor mechanisms of action in disease.

Main Results:

• HDAC inhibitors demonstrate significant anti-cancer activity.
• These inhibitors show potential in treating interstitial fibrosis and inflammatory conditions.
• HDAC inhibition impacts autoimmune diseases and metabolic disorders.

Conclusions:

• HDAC inhibitors represent a promising class of drugs for multiple diseases.
• Targeting HDACs offers a versatile therapeutic strategy for cancer, fibrosis, inflammation, and metabolic dysregulation.
• Further research into HDAC inhibitors is warranted for diverse clinical applications.